Canonical: https://ownershiptrace.com/13f/companies/3373

# Who owns SUPERNUS PHARMACEUTICALS, INC. (SUPN)? Elite investor 13F holders

5 tracked elite investors reported holding SUPERNUS PHARMACEUTICALS, INC as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Third Avenue Management, Tudor Investment, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree, a non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD); GOCOVRI for the treatment of dyskinesia and levodopa/carbidopa in patients with…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | SUPERNUS PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 68750152.00 USD | 1478180.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | SUPERNUS PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 35704239.00 USD | 767668.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Third Avenue Management](https://ownershiptrace.com/13f/investors/73) | SUPERNUS PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 7103193.00 USD | 152724.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1099281/0001099281-26-000008-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | SUPERNUS PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1150936.00 USD | 24746.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | SUPERNUS PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 345197.00 USD | 7422.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)